Fast infection diagnosis test for critically ill sepsis patients
Part of Infections clinical trials.
This study tests a new rapid test (NuRapid-CRISPR) that quickly identifies the bacteria or fungus causing a serious blood infection in ICU patients. The goal is to help doctors start the right treatment faster and improve patient outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older and admitted to ICU within the last 24 hours
- Have sepsis (a serious infection causing body inflammation) diagnosed by specific medical criteria
- Have an unknown infection that requires blood, fluid, or other specimen testing
- Be expected to stay in ICU for at least 48 hours and available for 28 days of follow-up
- Sign a consent form (you or a legal representative) agreeing to the test
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a quick DNA-based test to find bloodstream infections in ICU patients. If you are getting standard blood cultures for a suspected infection, you may be able to join.
This study tests whether a faster lab method can correctly identify the germ causing an infection and check which antibiotics may work, using samples taken in the emergency department. It may help doctors choose the right treatment sooner for people with serious suspected infection.
This trial is testing whether a new, highly sensitive blood test (droplet digital PCR) combined with genetic analysis can help doctors predict sepsis earlier in emergency room patients. This could lead to faster treatment and better outcomes.
This study aims to find new ways to quickly diagnose sepsis (a severe response to infection) in patients arriving at the emergency room. If successful, these new tests could help doctors start treatment faster.
This trial tests a new, faster way to find bacteria in the blood of children with suspected sepsis. It uses a molecular test that may give results sooner than standard cultures, helping doctors treat infections more quickly.
This trial is testing whether certain biomarkers (substances in your body) can help diagnose sepsis faster. Sepsis is a serious condition where your body has a severe response to an infection. The study will look at blood or other samples to see if these markers can quickly tell if you have sepsis, which could lead to faster treatment.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.